Effects of oral raloxifene on serum estradiol levels and other markers of estrogenicity

Fertility and Sterility

Volumn 78, Issue 3, 2002, Pages 469-472

  Reindollar, Richard ^a   Koltun, William ^b   Parsons, Anna ^c   Rosen, Amy ^d   Siddhanti, Suresh ^d   Plouffe Jr , Leo ^d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Medical Center for Clinical Research   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Estrogen; FSH; Raloxifene; Selective estrogen receptor modulator; Sex steroid binding globulin; Thyroxine binding globulin

Indexed keywords

ESTRONE; FOLLITROPIN; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE BINDING GLOBULIN; THYROXINE BINDING GLOBULIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ESTRADIOL; ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; MIDDLE AGED; PLACEBOS; POSTMENOPAUSE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEX HORMONE-BINDING GLOBULIN; THYROXINE-BINDING PROTEINS;

EID: 0036732151     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03288-0     Document Type: Article

References (7)

1. Selective estrogen receptor modulators (SERMs) in clinical practice
2. The effects of six months of treatment with a low-dose of conjugated oestrogens in menopausal women
3. Sex hormones in postmenopausal women with breast cancer on tamoxifen
4. Thyroid function in postmenopausal women with breast cancer on tamoxifen
5. Toremifene in postmenopausal breast cancer. Efficacy, safety and cost
6. Raloxifene; a review
7. Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3′, 5′-monophosphate and protein kinase A